Overall rank by patents
#31,644
Across all tracked assignees
USPTO PatentsView assignee record - 8 granted patents across 8 technology areas, active 2016–2024. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: A61M (DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY ; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY ; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR).
The verdict
Fresenius holds 8 US patents across 8 technology areas, rank #31,644 of 50,000 tracked assignees.
Fresenius KABI Austria Gmbh has been granted 8 US utility patents between 2016 and 2024, placing Fresenius KABI Austria Gmbh at rank #31,644 across all assignees tracked by PlainPatent. This portfolio spans 8 distinct Cooperative Patent Classification (CPC) subclasses, averaging 20.1 claims per patent with primary concentration in A61M (DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY ; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY ; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR). As a Foreign Corporation, Fresenius KABI Austria Gmbh is one of the more focused assignees in the PatentsView dataset. By volume, Fresenius sits between Fourth Military Medical University (8 patents, rank #31,640) and FTS Welding (8 patents, rank #31,648) - the closest US assignees by grant volume. The composite Innovation Score of 46.3/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Filing cadence tells the strategic story. Between 2020 and 2025 the company received 6 grants, compared with 2 in the 2015–2019 window, a +200% shift in five-year velocity. An acceleration of this magnitude signals aggressive R&D investment and expanding technical ambition. The Foreign Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.
Claim depth and technology breadth together indicate competitive posture. Fresenius KABI Austria Gmbh's 20.1 average claims per patent reflects complex, broadly scoped inventions that are difficult for competitors to design around, while concentration in 8 subclasses points to a focused technical program. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Fresenius KABI Austria Gmbh against peers pursuing similar technology classes.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
FOURTH MILITARY MEDICAL UNIVERSITY
8 patents
FOVIA, INC.
8 patents
FRANKLIN SPORTS, INC.
8 patents
FRANZ SCHNEIDER GMBH & CO. KG
8 patents
FRIESLAND BRANDS B.V.
8 patents
FRONTIIR PTE LTD.
8 patents
FS.COM LIMITED
8 patents
FTS WELDING
8 patents
FRESENIUS KABI AUSTRIA GMBH
8 patents
What this shows Fresenius holds 8 patents at rank #31,644, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #31,644 in granted patent volume.
Other assignees with the most granted patents in Fresenius's primary technology class.
Fresenius's Innovation Score vs. every tracked assignee
Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)
46 Top 21% higher than 79% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2016–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2016 | 1 | 12.5% |
| 2019 | 1 | 12.5% |
| 2020 | 1 | 12.5% |
| 2022 | 1 | 12.5% |
| 2023 | 3 | 37.5% |
| 2024 | 1 | 12.5% |
Top 8 of 8 technology areas
Overall rank by patents
#31,644
Across all tracked assignees
46.3 out of 100
How to use this portfolio
Fresenius's 8 grants land it in the top 21% by Innovation Score, but volume alone doesn't tell you where the strength sits.
Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.